Meng; Tze-Chiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meng; Tze-Chiang.The latest application filed is for "2 x 2 x 2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod".

Company Profile

6.9.22

Meng; Tze-Chiang - Lino Lakes MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod Grant 11,318,130 - Nordsiek , et al. May 3, 2	2022-05-03
2 x 2 x 2 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMOD App 20200276182 - Nordsiek; Michael T. ; et al.	2020-09-03
2.times.2.times.2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimod Grant 10,238,644 - Nordsiek , et al.	2019-03-26
Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis Grant 9,492,682 - Gold , et al. November 15, 2	2016-11-15
Method Of Treating Actinic Keratosis With 3.75% Imiquimod Cream App 20160303111 - Nordsiek; Michael T. ; et al.	2016-10-20
2.times.2.times.2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod Grant 9,370,509 - Nordsiek , et al. June 21, 2	2016-06-21
2 X 2 X 2 Week Dosing Regimen For Treating Actinic Keratosis With Pharmaceutical Compositions Formulated With 3.75 % Imiquimod App 20130210855 - NORDSIEK; Michael T. ; et al.	2013-08-15
Combination Therapy With Low Dosage Strength Imiquimod And Photodynamic Therapy To Treat Actinic Keratosis App 20130190715 - Gold; Michael H. ; et al.	2013-07-25
Lower Dosage Strength Imiquimod Formulations And Short Dosing Regimens For Treating Genital And Perianal Warts App 20120329825 - NORDSIEK; Michael T. ; et al.	2012-12-27
Lower Dosage Strength Imiquimod Formulations And Short Dosing Regimens For Treating Genital And Perianal Warts App 20120329824 - NORDSIEK; Michael T. ; et al.	2012-12-27
Lower Dosage Strength Imiquimod Formulations And Short Dosing Regimens For Treating Genital And Perianal Warts App 20120329823 - Nordsiek; Michael T. ; et al.	2012-12-27
Lower Dosage Strength Imiquimod Formulations And Short Dosing Regimens For Treating Genital And Perianal Warts App 20120289538 - NORDSIEK; Michael T. ; et al.	2012-11-15
Method of treating actinic keratosis with 3.75% imiquimod cream Grant 8,299,109 - Nordsiek , et al. October 30, 2	2012-10-30
2.times.2.times.2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod Grant 8,236,816 - Nordsiek , et al. August 7, 2	2012-08-07
2.times.2.times.2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimod Grant 8,222,270 - Nordsiek , et al. July 17, 2	2012-07-17
Combination Therapy With Cryosurgery And Low Dosage Strength Imiquimod To Treat Actinic Keratosis App 20110319811 - Nordsiek; Michael T. ; et al.	2011-12-29
3 x 3 x 3 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMOD App 20110263636 - Nordsiek; Michael T. ; et al.	2011-10-27
Lower Dosage Strength Pharmaceutical Compositions Formulated With 2.5% Imiquimod App 20110263634 - Nordsiek; Michael T. ; et al.	2011-10-27
Up To Six Weeks Treatment Regimen For Treating Actinic Keratoses With Pharmaceutical Compositions Formulated With 2.5% Imiquimod App 20110263633 - Nordsiek; Michael T. ; et al.	2011-10-27
Up To Six Weeks Dosing Regimen For Treating Actinic Keratosis With Pharmaceutical Compositions Formulated With 3.75% Imiquimod App 20110263637 - Nordsiek; Michael T. ; et al.	2011-10-27
Method Of Treating Actinic Keratosis With 3.75% Imiquimod Cream App 20110263635 - Nordsiek; Michael T. ; et al.	2011-10-27
2 x 2 x 2 WEEK TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD App 20110257216 - Nordsiek; Michael T. ; et al.	2011-10-20
2 x 2 x 2 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMOD App 20110257218 - Nordsiek; Michael T. ; et al.	2011-10-20
Lower Dosage Strength Pharmaceutical Compositions Forumlated With 3.75% Imiquimod App 20110257219 - Nordsiek; Michael T. ; et al.	2011-10-20
3 x 3 x 3 WEEK TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD App 20110257217 - Nordsiek; Michael T. ; et al.	2011-10-20
Lower Dosage Strength Imiquimod Formulations And Short Dosing Regimens For Treating Genital And Perianal Warts App 20110207766 - Nordsiek; Michael T. ; et al.	2011-08-25
Lower Dosage Strength Imiquimod Formulations And Shorter Dosing Regimens For Treating Actinic Keratoses App 20110021555 - Nordsiek; Michael T. ; et al.	2011-01-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.